UPDATE 2-Pfizer CFO Dave Denton to step down, leave company in August

CVS Health Corporation
Lowe's Companies, Inc.
Pfizer Inc.

CVS Health Corporation

CVS

0.00

Lowe's Companies, Inc.

LOW

0.00

Pfizer Inc.

PFE

0.00

Adds shares and background throughout

June 18 (Reuters) - Pfizer PFE.N said on Thursday that finance chief Dave Denton will step down and leave the U.S. drugmaker on August 15 to take a role in the consumer goods industry.

The company named Cecile Guegan, senior vice president of finance for its global biopharmaceutical business, as interim CFO, effective August 16.

Denton joined Pfizer as its finance head in 2022, having previously held positions at healthcare conglomerate CVS CVS.N and retail chain Lowe's Companies LOW.N.

Pfizer's top boss Albert Bourla said in a statement that Denton had helped guide the company through major transactions, including the buyouts of cancer therapy specialist Seagen, migraine drugmaker Biohaven and obesity drug developer Metsera.

Shares of the company were down 1.6% in premarket trading.

Pfizer said it will conduct an internal and external search for a permanent successor. Denton and Guegan will work together on the transition, the company said.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.